We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
-33.86%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$62.7M
AUM Growth
-$74.2M
Cap. Flow
-$27.2M
Cap. Flow %
-43.46%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$2.05M

Top Sells

Rank Stock Value
1
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$19.6M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$7.86M
3
QSI icon
Quantum-Si Incorporated
QSI
+$1.65M
4
CMPX icon
Compass Therapeutics
CMPX
+$191K
5
PHVS icon
Pharvaris
PHVS
+$18.4K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$6.26B
$23.5M 37.47%
3,733,381
– –
IRON icon
2
Disc Medicine
IRON
$3.03B
$11.4M 18.25%
243,513
– –
THRX
3
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$11.1M 17.63%
4,108,796
+523,450
+15% +$2.05M
ACRS icon
4
Aclaris Therapeutics
ACRS
$743M
$8.62M 13.75%
1,258,243
– –
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$4.94M 7.88%
3,525,957
– –
CMPX icon
6
Compass Therapeutics
CMPX
$349M
$2.46M 3.92%
1,246,977
-77,094
-6% -$191K
PHVS icon
7
Pharvaris
PHVS
$2.37B
$692K 1.1%
33,142
-1,000
-3% -$18.4K
QSI icon
8
Quantum-Si Incorporated
QSI
$157M
– –
-924,404
Closed -$1.65M
SLGC
9
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-3,403,276
Closed -$7.86M
PRDS
10
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-10,811,887
Closed -$19.6M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q3 2023 Portfolio in Review

As of Q3 2023, Foresite Capital Management V held 10 positions worth $62.7M, down 54% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V withdrew a net $27.2M in Q3 2023, closing 3 positions and reducing 2 holdings. Its most notable exit was Pardes Biosciences, Inc. Common Stock, an estimated $19.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Foresite Capital Management V added an estimated $2.05M to Theseus Pharmaceuticals, Inc. Common Stock.

  • Foresite Capital Management V added most to Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023, an estimated $2.05M increase.
  • Foresite Capital Management V's biggest Q3 2023 reduction was Compass Therapeutics, cutting an estimated $191K.
  • Foresite Capital Management V fully exited Pardes Biosciences, Inc. Common Stock in Q3 2023, selling an estimated $19.6M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $62.7M portfolio in Q3 2023.
  • Foresite Capital Management V opened 0 new positions and closed 3 in Q3 2023.
  • Foresite Capital Management V's portfolio value fell 54% quarter-over-quarter to $62.7M.

Based on Foresite Capital Management V's 13F filing for Q3 2023, filed 13 Nov 2023.